Dermata Therapeutics Stock (NASDAQ: DRMA) stock price, news, charts, stock research, profile.
You can purchase shares of Dermata Therapeutics (NASDAQ:DRMA) through any online brokerage.
Other companies in Dermata Therapeutics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Entero Therapeutics (NASDAQ:ENTO), Bone Biologics (NASDAQ:BBLG), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Shuttle Pharmaceuticals (NASDAQ:SHPH).
Dermata Therapeutics has a consensus price target of $6.00.
The stock price for Dermata Therapeutics (NASDAQ: DRMA) is $1.14 last updated December 20, 2024 at 7:58 PM EST.
There are no upcoming dividends for Dermata Therapeutics.
Dermata Therapeutics’s Q4 earnings are confirmed for Thursday, March 20, 2025.
There is no upcoming split for Dermata Therapeutics.
Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.